Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Mahadevia Ankit Create: Alert

All | News | Filings
Date FiledTypeDescription
10/10/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/06/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/29/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/30/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/03/2021 4 Mahadevia Ankit (See Remarks) has filed a Form 4 on Spero Therapeutics, Inc.
Txns: Granted 179,319 options to buy @ $19.18, valued at $3.4M
11/05/2020 4 Mahadevia Ankit (CEO and President) has filed a Form 4 on Spero Therapeutics, Inc.
Txns: Sold 2,137 shares @ $14.2675, valued at $30.5k
Sold 7,370 shares @ $14.4281, valued at $106.3k
Exercised 2,137 options to buy @ $5.9, valued at $12.6k
Exercised 7,370 options to buy @ $5.9, valued at $43.5k
10/27/2020 4 Mahadevia Ankit (CEO and President) has filed a Form 4 on Spero Therapeutics, Inc.
Txns: Sold 20 shares @ $14.25, valued at $285
Exercised 20 options to buy @ $5.9, valued at $118
10/15/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/10/2020 4 Mahadevia Ankit (CEO and President) has filed a Form 4 on Spero Therapeutics, Inc.
Txns: Sold 774 shares @ $14.2503, valued at $11k
Exercised 774 options to buy @ $5.9, valued at $4.6k
07/09/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/29/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/03/2020 4 Mahadevia Ankit (CEO and President) has filed a Form 4 on Spero Therapeutics, Inc.
Txns: Granted 180,000 options to buy @ $9.34, valued at $1.7M
01/02/2019 4 Mahadevia Ankit (CEO and President) has filed a Form 4 on Spero Therapeutics, Inc.
Txns: Granted 180,000 options to buy @ $6.26, valued at $1.1M
07/06/2018 4 Mahadevia Ankit (See Remarks) has filed a Form 4 on Spero Therapeutics, Inc.
Txns: Sold 3,076 shares @ $17.6215, valued at $54.2k
Sold 500 shares @ $17.5, valued at $8.8k
Sold 100 shares @ $17.545, valued at $1.8k
Sold 400 shares @ $17.58, valued at $7k
Sold 100 shares @ $17.62, valued at $1.8k
Sold 100 shares @ $17.705, valued at $1.8k
Sold 200 shares @ $17.9, valued at $3.6k
Sold 200 shares @ $17.92, valued at $3.6k
Exercised 3,076 options to buy @ $5.9, valued at $18.1k
Exercised 1,600 options to buy @ $5.9, valued at $9.4k
12/15/2017 4 Mahadevia Ankit (See Remarks) has filed a Form 4 on Spero Therapeutics, Inc.
Txns: Granted 125,079 options to buy @ $11.63, valued at $1.5M
11/01/2017 3 Mahadevia Ankit (See Remarks) has filed a Form 3 on Spero Therapeutics, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy